Analysts at JPMorgan Chase & Co. upgraded shares of Synageva BioPharma Corp. (NASDAQ:GEVA) from a neutral rating to an overweight rating in a research note on Monday, February 10th. Synageva BioPharma Corp (NASDAQ:GEVA) shares after opening at $76.73 moved to $83.89 on last trade day and at the end of the day closed at $ 82.97. Company price to sales ratio in past twelve months was calculated as 203.96 and price to cash ratio as 6.69. Synageva BioPharma Corp (NASDAQ:GEVA) showed a positive weekly performance of 2.38%.
Pacira Pharmaceuticals (NASDAQ:PCRX) was upgraded by research analysts at Piper Jaffray from a “neutral” rating to an “overweight” rating in a report released on Tuesday, AnalystRatings.Net reports. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) shares advanced 10.73% in last trading session and ended the day on $69.99. PCRX return on equity ratio is recorded as -158.90% and its return on assets is -49.40%. Pacira Pharmaceuticals Inc (NASDAQ:PCRX) yearly performance is 145.06%.
Alnylam Pharmaceuticals, Inc (NASDAQ:ALNY) saw a big move last session, as the company’s shares fell by over 5% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for ALNY, as the stock is now down about 23% in the past one-month time frame. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) shares moved up 8.75% in last trading session and was closed at $67.14 while trading in range of $61.75 -$67.86 – Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) year to date (YTD) performance is 4.42%.
CommScope Holding Company, Inc. (NASDAQ:COMM)’s stock fell 1.47% to $22.76. The company on Mar. 27 has priced its secondary offering of 17,500,000 shares of its common stock at $22.00 per share. All of the shares of common stock offered are being sold by an affiliate of The Carlyle Group (the “selling stockholder”). Commscope Holding Company Inc (NASDAQ:COMM) weekly performance is 1.02%. On last trading day company shares ended up $24.68. Commscope Holding Company Inc (NASDAQ:COMM) distance from 50-day simple moving average (SMA50) is 18.93%. Analysts mean target price for the company is $25.33.